INVO Bioscience (INVO) Tops Q2 EPS by 2c

INVO Bioscience (NASDAQ: INVO) reported Q2 EPS of ($0.17), $0.02 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $208.5 thousand versus the consensus estimate of $410 thousand.

For earnings history and earnings-related data on INVO Bioscience (INVO) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Sypris Solutions (SYPR) Reports Q2 Loss of $0.14
• Baidu slips as Q2 results miss estimates despite growth in AI cloud business